Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
|
|
KalVista Pharmaceuticals, Inc. (KALV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/22/2023 |
4/A
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 2,430 options to buy
@ $0 |
|
| 05/22/2023 |
4/A
| Palleiko Benjamin L (President, CFO, CBO & Sec'y) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 6,944 options to buy
@ $0 |
|
| 05/22/2023 |
4/A
| Feener Edward P. (Chief Scientific Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 2,430 options to buy
@ $0 |
|
| 05/22/2023 |
4/A
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 6,944 options to buy
@ $0 |
|
| 05/22/2023 |
4/A
| Audhya Paul K. (Chief Medical Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 4,027 options to buy
@ $0 |
|
| 05/07/2021 |
4/A
| Feener Edward P. (Chief Scientific Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 6,000 shares
@ $24.8418, valued at
$149.1k
|
|
| 01/24/2019 |
4/A
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 116,810 options to buy
@ $0 |
|
| 09/18/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/27/2015 |
4/A
| CHA ALBERT (Director) has filed a Form 4 on Carbylan Therapeutics, Inc.|
Txns:
| Converted 2,476,452 shares
@ $0
Converted 18,140 shares
@ $0
Converted 387,960 shares
@ $0
Converted 2,842 shares
@ $0
Converted 304,438 shares
@ $0
Converted 2,230 shares
@ $0
Bought 1,005,136 shares
@ $5, valued at
$5M
Bought 7,364 shares
@ $5, valued at
$36.8k
Converted 2,476,452 convertible preferred
@ $0
Converted 18,140 convertible preferred
@ $0
Converted 387,960 convertible notes
@ $0 |
|
| 04/24/2015 |
4/A
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 4 on Carbylan Therapeutics, Inc.|
Txns:
| Converted 2,476,452 shares
@ $0
Converted 18,140 shares
@ $0
Converted 387,960 shares
@ $0
Converted 2,842 shares
@ $0
Converted 304,438 shares
@ $0
Converted 2,230 shares
@ $0
Bought 1,005,136 shares
@ $5, valued at
$5M
Bought 7,364 shares
@ $5, valued at
$36.8k
Converted 2,476,452 convertible preferred
@ $0
Converted 18,140 convertible preferred
@ $0
Converted 387,960 convertible notes
@ $0 |
|
|
|